Analysed DIAMEDICA THERAPEUTICS INC (DMAC:NASDAQ) News Sources
RedChip's April 16 Virtual Investor Conference to Feature Companies Advancing Clinical Pipelines and Scalable Healthcare Platforms
07-04-2026
yahoo.com
DiaMedica Therapeutics Highlights DM199 Preeclampsia Data, Stroke Interim Catalyst at RedChip Conference
16-04-2026
marketbeat.com
DiaMedica Therapeutics to Report First Quarter 2026 Financial Results and Provide a Business Update May 7, 2026
30-04-2026
yahoo.com
DiaMedica Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Highlights
06-05-2026
yahoo.com
DiaMedica Therapeutics (NASDAQ:DMAC) Is In A Good Position To Deliver On Growth Plans
10-05-2026
yahoo.com
DiaMedica Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference
12-05-2026
yahoo.com
DiaMedica Therapeutics Announces 75% Enrollment Milestone in ReMEDy2 Phase 2/3 Acute Ischemic Stroke Trial
20-05-2026
yahoo.com
What is the current price of DIAMEDICA THERAPEUTICS INC (DMAC:NASDAQ)?
The current price of DIAMEDICA THERAPEUTICS INC (DMAC:NASDAQ) is $5.89.
DIAMEDICA THERAPEUTICS INC (DMAC:NASDAQ) absolute price change since previous trading day?
The absolute price change of DIAMEDICA THERAPEUTICS INC (DMAC:NASDAQ) since the previous trading day is $-0.1.
DIAMEDICA THERAPEUTICS INC (DMAC:NASDAQ) percentage price change since previous trading day?
The percentage price change of DIAMEDICA THERAPEUTICS INC (DMAC:NASDAQ) since the previous trading day is -1.6694%.
What is the most recent average sentiment score for DIAMEDICA THERAPEUTICS INC (DMAC:NASDAQ)?
The most recent average sentiment score for DIAMEDICA THERAPEUTICS INC (DMAC:NASDAQ) is 84 out of 100.
What is the most recent average sentiment for DIAMEDICA THERAPEUTICS INC (DMAC:NASDAQ)?
The most recent sentiment for DIAMEDICA THERAPEUTICS INC (DMAC:NASDAQ) is .
SEC-8K** Filing Available For DIAMEDICA THERAPEUTICS INC (DMAC:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.